Clinical Trial Update: Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) [NA]

View source ↗

Summary

BIORISE is a clinical trial evaluating predictive biomarkers for hypersensitivity to radiation in breast cancer. The study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Breast Cancer | NA | Status: ACTIVE_NOT_RECRUITING